Benjamin Malcolm

642 total citations
15 papers, 427 citations indexed

About

Benjamin Malcolm is a scholar working on Clinical Psychology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Benjamin Malcolm has authored 15 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Clinical Psychology, 6 papers in Cellular and Molecular Neuroscience and 5 papers in Pharmacology. Recurrent topics in Benjamin Malcolm's work include Psychedelics and Drug Studies (7 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Treatment of Major Depression (4 papers). Benjamin Malcolm is often cited by papers focused on Psychedelics and Drug Studies (7 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Treatment of Major Depression (4 papers). Benjamin Malcolm collaborates with scholars based in United States, Canada and South Africa. Benjamin Malcolm's co-authors include Kelan Thomas, Kimberly Tallian, Joseph P. Barsuglia, Kelly C. Lee, Christopher S. Stauffer, David Feifel, Benjamin Kelmendi, Robert L. Palmer, Junhua Yu and Sandy L. Dong and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Affective Disorders and Psychopharmacology.

In The Last Decade

Benjamin Malcolm

15 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin Malcolm United States 10 242 148 133 63 50 15 427
E.A.V. Marinho Brazil 11 212 0.9× 80 0.5× 212 1.6× 112 1.8× 19 0.4× 27 478
Blair Steele Jamaica 6 168 0.7× 106 0.7× 99 0.7× 219 3.5× 39 0.8× 8 457
Joel Porfírio Pinto Brazil 10 232 1.0× 77 0.5× 222 1.7× 291 4.6× 15 0.3× 23 668
Henry Lowe Jamaica 13 172 0.7× 127 0.9× 103 0.8× 271 4.3× 74 1.5× 29 794
Gabriela de Oliveira Silveira Brazil 13 217 0.9× 94 0.6× 104 0.8× 65 1.0× 14 0.3× 24 427
Mercedes Yritia Spain 6 302 1.2× 105 0.7× 205 1.5× 149 2.4× 12 0.2× 11 557
Jonathan Ott Mexico 9 302 1.2× 126 0.9× 122 0.9× 77 1.2× 24 0.5× 23 400
Peter H. Addy United States 8 257 1.1× 90 0.6× 221 1.7× 207 3.3× 25 0.5× 10 506
Lionel P. Raymon United States 10 321 1.3× 93 0.6× 176 1.3× 156 2.5× 11 0.2× 14 696
Shibley Rahman Bangladesh 13 25 0.1× 139 0.9× 49 0.4× 46 0.7× 39 0.8× 29 1.1k

Countries citing papers authored by Benjamin Malcolm

Since Specialization
Citations

This map shows the geographic impact of Benjamin Malcolm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Malcolm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Malcolm more than expected).

Fields of papers citing papers by Benjamin Malcolm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Malcolm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Malcolm. The network helps show where Benjamin Malcolm may publish in the future.

Co-authorship network of co-authors of Benjamin Malcolm

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Malcolm. A scholar is included among the top collaborators of Benjamin Malcolm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Malcolm. Benjamin Malcolm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Thomas, Kelan, et al.. (2022). Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review. Psychopharmacology. 239(6). 1945–1976. 45 indexed citations
2.
Thompson, Caitlin S., et al.. (2022). Use of Phyllomedusa bicolour secretion during kambô ritual: observational responses, dosage, and risk of adverse events. SHILAP Revista de lepidopterología. 6(1). 6–12. 1 indexed citations
3.
Malcolm, Benjamin & Kelan Thomas. (2021). Serotonin toxicity of serotonergic psychedelics. Psychopharmacology. 239(6). 1881–1891. 75 indexed citations
4.
Malcolm, Benjamin, et al.. (2020). Persistent Tinnitus after Inhaled N,N-dimethyltryptamine (DMT). Journal of Psychoactive Drugs. 53(2). 140–145. 1 indexed citations
5.
Malcolm, Benjamin, et al.. (2020). Eucalyptol (1,8-cineole): an underutilized ally in respiratory disorders?. Journal of Essential Oil Research. 32(2). 103–110. 40 indexed citations
6.
Lee, Kelly C., et al.. (2020). Development of an innovative adult attention-deficit hyperactivity disorder clinic. Mental Health Clinician. 10(5). 296–300. 5 indexed citations
7.
Malcolm, Benjamin, et al.. (2019). Effect of long-acting aripiprazole monohydrate on inpatient encounters: A retrospective mirror image study. Mental Health Clinician. 9(4). 258–262. 2 indexed citations
8.
Barsuglia, Joseph P., et al.. (2018). A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder. Progress in brain research. 242. 121–158. 25 indexed citations
9.
Malcolm, Benjamin, et al.. (2018). Changes in Withdrawal and Craving Scores in Participants Undergoing Opioid Detoxification Utilizing Ibogaine. Journal of Psychoactive Drugs. 50(3). 256–265. 45 indexed citations
10.
Malcolm, Benjamin, Laura Murphy, & Michael Pak-Kai Wong. (2018). Should Medical Cannabis Administered by Inhalation Be Allowed for Hospitalized Patients?. The Canadian Journal of Hospital Pharmacy. 71(3). 211–214. 1 indexed citations
11.
Thomas, Kelan, et al.. (2017). Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders. Journal of Psychoactive Drugs. 49(5). 446–455. 52 indexed citations
12.
Feifel, David, et al.. (2017). Low-dose ketamine for treatment resistant depression in an academic clinical practice setting. Journal of Affective Disorders. 221. 283–288. 28 indexed citations
13.
Malcolm, Benjamin & Kelly C. Lee. (2017). Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness?. Mental Health Clinician. 7(1). 39–45. 19 indexed citations
14.
Malcolm, Benjamin & Kimberly Tallian. (2017). Essential oil of lavender in anxiety disorders: Ready for prime time?. Mental Health Clinician. 7(4). 147–155. 73 indexed citations
15.
Malcolm, Benjamin, et al.. (2014). Effects of a student pharmacist consultation on patient knowledge and attitudes about vaccines. Journal of the American Pharmacists Association. 54(2). 130–137. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026